Is the combination of mitomycin C, bleomycin and methotrexate effective as a neoadjuvant treatment for cervical cancer in women?

European Journal of Gynaecological Oncology

Volumn 32, Issue 1, 2011, Pages 37-39

  Pinheiro, W ^a   Cavalcante Pereira, A K ^a   Soares Jr , J M ^a   Baracat, E C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bleomycin; Cervical cancer; Chemotherapy; Methotrexate; Mitomycin

Indexed keywords

BLEOMYCIN; METHOTREXATE; MITOMYCIN C;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INJECTION SITE NECROSIS; LEUKOPENIA; MORTALITY; MULTIPLE CYCLE TREATMENT; NAUSEA; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; UTERINE CERVICAL NEOPLASMS;

EID: 79952335747     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sherris J., Herdman C., Elias C.: "Cervical cancer in the developing world". West. J. Med., 2001, 175, 231.
2. Perez C.A., Grigsby P.W., Chao K.S., Mutch D.G., Lockett M.A.: "Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1998, 41, 307.
3. nd, Schorge J.O., Duska L.A., Crum C.P., Castrillon D.H., Sheets E.E.: "Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix". Gynecol. Oncol., 2001, 81, 82.
4. Pecorelli S., Odicino F.: "Cervical cancer staging". Cancer J., 2003, 9, 390.
5. Gray H.J.: "Primary management of early stage cervical cancer (IAl-IB) and appropriate selection of adjuvant therapy". J. Natl. Compr. Canc. Netw., 2008, 6, 47.
6. Monk B.J., Tian C., Rose P.G., Lanciano R.: "Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials". Gynecol. Oncol., 2007, 105, 427.
7. Kim D.S., Moon H., Hwang Y.Y., Cho S.H.: "Preoperative adjuvant chemotherapy in the treatment of cervical cancer Stages Ib, IIa and IIb with bulky tumor". Gynecol. Oncol., 1988, 29, 321.
8. Muscato M.S., Perry M.C., Yarbso J.W.: "Chemotherapy of cervical carcinoma". Semin. Oncol., 1982, 9, 373.
9. Sismondi P., Giail M., Mano M.P., Cavalcanti T.C., Lamberto A.: "Tossicità midollare della chemioterapia nei tumori ginecologici". Minerva Ginecol., 1985, 37, 27.
10. Kokawa K., Nishimura R., Fujii T., Umesaki N.: "Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix". Anticancer Res., 2007, 27, 2721.
11. Umezawa K., Nakazawa K., Uchihata Y., Otsuka M.: "Screening for inducers of apoptosis in apoptosis-resistant human carcinoma cells". Adv. Enzyme Regul., 1999, 39, 145.
12. Isonishi S., Terashima Y.: "Methotrexate in gynecologic oncology". Gan To Kagaku Ryoho., 1996, 23, 1896.
13. Chen J., Macdonald O.K., Gaffney D.K.: "Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix". Obstet. Gynecol., 2008, 111, 1394.
14. Tierney J.F., Vale C., Symonds P.: "Concomitant and neoadjuvant chemotherapy for cervical cancer". Clin. Oncol. (R. Coll. Radiol.), 2008, 20, 401.
15. Friedlander M.L., Atkinson K., Coppleson J.V.M., Elliot P., Green D., Houghton R. et al.: "The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study". Gynecol. Oncol., 1984, 19, 1.
16. Kim D.S., Moon H., Hwang Y.Y., Cho S.H.: "Preoperative adjuvant chemotherapy in the treatment of cervical cancer Stages Ib, IIa and IIb with bulky tumor". Gynecol. Oncol., 1988, 29, 321.
17. Rustin G.J.S., Newlands E.S., Southcott B., Singer A.: "Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix". Br. J. Obstet. Gynaecol., 1987, 94, 1205.